Patients with haematological cancers are at higher risk of COVID-19 infection and experience more severe disease compared to people with other...
Myeloma NZ
Spain Reviewing Trial to Treat COVID-19 Pneumonia With Myeloma Therapy Aplidin
Madrid-based PharmaMar has submitted the protocol for a Phase 2 trial to the Spanish Medicines and Healthcare Products Agency (AEMPS) to test its...
Genetic Test Could Determine Patients With Ultra High Risk Multiple Myeloma
A new study published in Leukemia revealed that researchers at the Institute of Cancer Research in London have found a new genetic test that could...
First case of COVID-19 in a patient with multiple myeloma
The immunosuppressant tocilizumab may be a promising option for myeloma patients with COVID-19, a case study from China suggests. Dr Changcheng...
Genetic Test Identifies Ultra-High-Risk Myeloma Patients
A new test can identify patients with multiple myeloma (MM) who have a high-risk genetic profile as well as multiple chromosomal abnormalities. In...
WEBINAR: Leading experts to give their views on treating multiple myeloma patients during the COVID-19 pandemic
The COVID-19 pandemic continues to put a strain on healthcare delivery around the world. In this environment, haematologists are adapting their...
First Report of MM Patient Successfully Treated for COVID-19 With Tocilizumab
Recent research has shown that severe cases of COVID-19 show an excessive immune response and a strong cytokine storm, which may include high levels...
Ygalo Shows Positive Response in Triple-refractory Multiple Myeloma Trial
Topline results show a 26% response rate in a Phase 2 clinical trial evaluating Ygalo (melflufen) in patients with triple-refractory multiple...
The squeeze on healthcare in locked-down New Zealand
Medical centres across the country are condensing services, moving online and ushering in pandemic plans. Josie Adams assesses what it’s like to...
Treating COVID-19 in a patient with multiple myeloma
A case study of a patient in Wuhan, China, suggests that the immunosuppressant tocilizumab may be an effective COVID-19 treatment for very ill...
Pharmac widens funding for lenalidomide for those with blood cancer
Emma Holden was devastated when she learned she had multiple myeloma. The 31-year-old, who lives in South Canterbury, was diagnosed with the form of...
An open letter to the Prime Minister of New Zealand, Jacinda Ardern
The Patient Voice Aotearoa team, with support from 35 patient advocacy groups, today published a full page ad in the Herald calling on the Prime...